サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1416735

補助人工心臓市場レポート：2030年までの動向、予測、競合分析

Ventricular Assist Device Market Report: Trends, Forecast and Competitive Analysis to 2030

出版日
発行
Lucintel
ページ情報
英文 150 - page report
納期
3営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

補助人工心臓市場レポート：2030年までの動向、予測、競合分析
出版日: 2024年01月29日
発行: Lucintel
ページ情報: 英文 150 - page report
納期: 3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

補助人工心臓の動向と予測

世界の補助人工心臓市場は、2024～2030年のCAGRが10.5%で、2030年までに推定32億米ドルに達すると予想されています。この市場の主要促進要因は、心不全の有病率の上昇と心血管疾患の患者数の増加です。世界の補助人工心臓市場の将来は、移植への橋渡し、目的地治療、回復への橋渡し、治療候補への橋渡しの用途における機会があり、有望に見えます。

補助人工心臓市場別洞察

Lucintelは、植え込み型補助人工心臓は、心臓のポンプ機能を改善するために心臓疾患を持つ患者の間で使用が増加しているため、予測期間中にさらに高い成長が見込まれると予測しています。

この市場の中で、デスティネーションセラピーは最も高い成長を遂げると予想されています。

北米は、強力な医療システムの存在と地域の主要企業の存在により、予測期間中に最高の成長を遂げると予想されています。

よくある質問

Q1.市場規模は：

A1.世界の補助人工心臓市場は、2030年までに推定32億米ドルに達すると予想されています。

Q2.市場の成長予測は：

A2.世界の補助人工心臓市場は、2024～2030年にかけて10.5%のCAGRで成長すると予想されています。

Q3.市場の成長に影響を与える主要促進要因は：

A3.この市場の主要促進要因は、心不全の有病率の上昇と心血管疾患の患者数の増加です。

Q4.市場の主要セグメントは：

A4.補助人工心臓市場の将来は、移植への橋渡し、目的地治療、回復への橋渡し、治療候補への橋渡しの用途における機会があり、有望に見えます。

Q5.市場の主要企業は：

A5.主要な補助人工心臓会社は次のとおりです。

  • Abbott Laboratories
  • Corewave
  • Bivacor
  • Carmat
  • Jarvik Heart

Q6.今後、最大となる市場セグメントは：

A6.Lucintelは、植え込み型補助人工心臓は、心臓のポンプ機能を改善するために心臓疾患を持つ患者の間で使用が増加しているため、予測期間中にさらに高い成長が見込まれると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は：

A7.北米は、強力な医療システムの存在と地域の主要企業の存在により、予測期間中に最高の成長を遂げると予想されています。

Q8.レポートのカスタマイズは可能か：

A8.はい、Lucintelは追加費用なしで10%のカスタマイズを記載しています。

目次

第1章 エグゼクティブサマリー

第2章 世界の補助人工心臓市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018～2030年の市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界の補助人工心臓市場動向（2018～2023年）と予測（2024～2030年）
  • 設計別の世界の補助人工心臓市場
    • 経皮的心室補助装置
    • 植込み型補助人工心臓
  • 製品別の世界の補助人工心臓市場
    • 左心室補助装置（LVAD）
    • 右心室補助装置（RVAD）
    • 両心室補助装置（BIVAD）
  • 用途別の世界の補助人工心臓市場
    • 移植への橋渡し
    • デスティネーションセラピー
    • 回復への橋渡し
    • 候補療法への橋渡し
  • 最終用途別の世界の補助人工心臓市場
    • 外来手術センター
    • 病院
    • その他

第4章 2018～2030年の地域別の市場動向と予測分析

  • 地域別の世界の補助人工心臓市場
  • 北米の補助人工心臓市場
  • 欧州の補助人工心臓市場
  • アジア太平洋の補助人工心臓市場
  • その他地域の補助人工心臓市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • 設計別の世界の補助人工心臓市場の成長機会
    • 製品別の世界の補助人工心臓市場の成長機会
    • 用途別の世界の補助人工心臓市場の成長機会
    • 最終用途別の世界の補助人工心臓市場の成長機会
    • 地域別の世界の補助人工心臓市場の成長機会
  • 世界の補助人工心臓市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界の補助人工心臓市場の生産能力の拡大
    • 世界の補助人工心臓市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Abbott Laboratories
  • Corewave
  • Bivacor
  • Carmat
  • Jarvik Heart
目次

Ventricular Assist Device Trends and Forecast

The future of the global ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications. The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.

A more than 150-page report is developed to help in your business decisions.

Ventricular Assist Device by Segment

The study includes a forecast for the global ventricular assist device by design, product, application, end use, and region.

Ventricular Assist Device Market by Design [Shipment Analysis by Value from 2018 to 2030]:

  • Transcutaneous Ventricular Assist Devices
  • Implantable Ventricular Assist Devices

Ventricular Assist Device Market by Product [Shipment Analysis by Value from 2018 to 2030]:

  • Left Ventricular Assist Devices (LVADs)
  • Right Ventricular Assist Devices (RVADs)
  • Biventricular Assist Devices (BIVADs)

Ventricular Assist Device Market by Application [Shipment Analysis by Value from 2018 to 2030]:

  • Bridge-to-Transplant
  • Destination Therapy
  • Bridge-to-Recovery
  • Bridge to Candidacy Therapy

Ventricular Assist Device Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

  • Ambulatory Surgery Centers
  • Hospital
  • Others

Ventricular Assist Device Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Ventricular Assist Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies ventricular assist device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the ventricular assist device companies profiled in this report include-

  • Abbott Laboratories
  • Corewave
  • Bivacor
  • Carmat
  • Jarvik Heart

Ventricular Assist Device Market Insights

Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.

Within this market, destination therapy is expected to witness the highest growth.

North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.

Features of the Global Ventricular Assist Device Market

Market Size Estimates: Ventricular assist device market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Ventricular assist device market size by various segments, such as by design, product, application, end use, and region in terms of value ($B).

Regional Analysis: Ventricular assist device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different designs, products, applications, end uses, and regions for the ventricular assist device market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the ventricular assist device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the ventricular assist device market size?

Answer: The global ventricular assist device market is expected to reach an estimated $3.2 billion by 2030.

Q2. What is the growth forecast for ventricular assist device market?

Answer: The global ventricular assist device market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the ventricular assist device market?

Answer: The major drivers for this market are rising prevalence of heart failure and growing number of patients with cardiovascular disease.

Q4. What are the major segments for ventricular assist device market?

Answer: The future of the ventricular assist device market looks promising with opportunities in the bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy applications.

Q5. Who are the key ventricular assist device market companies?

Answer: Some of the key ventricular assist device companies are as follows:

  • Abbott Laboratories
  • Corewave
  • Bivacor
  • Carmat
  • Jarvik Heart

Q6. Which ventricular assist device market segment will be the largest in future?

Answer: Lucintel forecasts that implantable ventricular assist device is expected to witness the higher growth over the forecast period due to its rising usage among patients with heart issue to improve the pumping function of the heart.

Q7. In ventricular assist device market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to existence of strong healthcare system and presence of key players in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the ventricular assist device market by design (transcutaneous ventricular assist devices and implantable ventricular assist devices), product (left ventricular assist devices, right ventricular assist devices, and biventricular assist devices), application (bridge-to-transplant, destination therapy, bridge-to-recovery, and bridge to candidacy therapy), end use (ambulatory surgery centers, hospital, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Ventricular Assist Device Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Ventricular Assist Device Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Ventricular Assist Device Market by Design
    • 3.3.1: Transcutaneous Ventricular Assist Devices
    • 3.3.2: Implantable Ventricular Assist Devices
  • 3.4: Global Ventricular Assist Device Market by Product
    • 3.4.1: Left Ventricular Assist Devices (LVADs)
    • 3.4.2: Right Ventricular Assist Devices (RVADs)
    • 3.4.3: Biventricular Assist Devices (BIVADs)
  • 3.5: Global Ventricular Assist Device Market by Application
    • 3.5.1: Bridge-to-Transplant
    • 3.5.2: Destination Therapy
    • 3.5.3: Bridge-to-Recovery
    • 3.5.4: Bridge to Candidacy Therapy
  • 3.6: Global Ventricular Assist Device Market by End Use
    • 3.6.1: Ambulatory Surgery Centers
    • 3.6.2: Hospital
    • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Ventricular Assist Device Market by Region
  • 4.2: North American Ventricular Assist Device Market
    • 4.2.2: North American Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
  • 4.3: European Ventricular Assist Device Market
    • 4.3.1: European Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
    • 4.3.2: European Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
  • 4.4: APAC Ventricular Assist Device Market
    • 4.4.1: APAC Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
    • 4.4.2: APAC Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy
  • 4.5: ROW Ventricular Assist Device Market
    • 4.5.1: ROW Ventricular Assist Device Market by Design: Transcutaneous Ventricular Assist Devices and Implantable Ventricular Assist Devices
    • 4.5.2: ROW Ventricular Assist Device Market by Application: Bridge-to-Transplant, Destination Therapy, Bridge-to-Recovery, and Bridge to Candidacy Therapy

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Ventricular Assist Device Market by Design
    • 6.1.2: Growth Opportunities for the Global Ventricular Assist Device Market by Product
    • 6.1.3: Growth Opportunities for the Global Ventricular Assist Device Market by Application
    • 6.1.4: Growth Opportunities for the Global Ventricular Assist Device Market by End Use
    • 6.1.5: Growth Opportunities for the Global Ventricular Assist Device Market by Region
  • 6.2: Emerging Trends in the Global Ventricular Assist Device Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Ventricular Assist Device Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Ventricular Assist Device Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Abbott Laboratories
  • 7.2: Corewave
  • 7.3: Bivacor
  • 7.4: Carmat
  • 7.5: Jarvik Heart